Efficacy and safety of convalescent plasma therapy in patients with moderate-to-severe COVID-19: A non-randomized comparative study with historical control in a referral hospital in Indonesia

• Prif Awduron: Johan Kurnianda (Awdur), Mardiah S. Hardianti (Awdur), Teguh Triyono (Awdur), Jarir A. Thobari (Awdur), Ika Trisnawati (Awdur), Calcarina F.R. Wisudarti (Awdur), Usi Sukorini (Awdur), Fuad Anshori (Awdur), Syahru A. Setiawan (Awdur), Meita Ucche (Awdur), Abrid Farahnaz (Awdur), Yana Suryani (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Elsevier, 2022-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Background: Studies to confirm the efficacy and safety of convalescent plasma (CP) as an adjunctive treatment for COVID-19 are still required especially for the countries where standard treatments are unevenly distributed. Methods: A non-randomized comparative study was done from June - September 20...